Eight Advisory supported Sapio Group on its acquisition of Baywater Healthcare

Sapio Group, founded in 1922 and headquartered in Monza, Italy, is a leading producer and supplier of industrial and medical gases. With over 2,300 employees, Sapio operates across Italy and has a presence in France, Germany, Spain, Slovenia, and Turkey. The company offers a comprehensive range of products and services, including oxygen, nitrogen, hydrogen, and medical gases, serving various industries such as healthcare, chemicals, and energy.  

Baywater Healthcare, founded in 2013 and based in Crewe, Cheshire, is a prominent provider of home respiratory care services in the United Kingdom. The company offers a range of services, including oxygen therapy, sleep apnoea management, and non-invasive ventilation, aiming to enhance the quality of life for patients with long-term respiratory conditions. Baywater Healthcare employs approximately 500 people and operates a 24-hour call centre to support its services.  

The acquisition aims at expanding Sapio Group’s presence in the home healthcare sector, particularly in respiratory care services. By integrating Baywater Healthcare’s expertise and infrastructure, Sapio seeks to enhance its service offerings and strengthen its position in the growing homecare market. 

Eight Advisory team members supporting this transaction:  

• Financial due diligence: Alison Harutunian (Partner), Martin Rouault (Senior) 

• Tax due diligence: Caley Mogg (Partner), Phoebe Lightfoot (Manager)